On-Demand Catalog

All sessions average between 60 and 90 minutes.

FDA’s COVID-19 Activities
The Regulation of Biologics and Biosimilars: An Introduction
Post Approval Requirements for Drugs: An Introduction to Safety Reporting and Post-Approval Changes
An Introduction to the Abbreviated NDA (ANDA), 505(b)(2) Applications, and Patent and Exclusivity Issues
The New Drug Approval Process: NDA Submission and Review
The New Drug Approval Process: New Drug Research and Development
The New Drug Approval Process: Basic Concepts
Origins and Overview of Drug Law Regulation: An Introduction
FDA’s Expedited Programs: Understanding Which Program Best Suits Your Product
Food Law in China: Overview, Practical Considerations, and Recent Developments

Filter Results